Kyverna Therapeutics宣布拟公开募股1亿美元

2025-12-16 05:40

Kyverna Therapeutics (NASDAQ:KYTX) announced on Monday that it has commenced an underwritten public offering of $100M of shares, and underwriters will be granted a 30-day option to purchase up to an additional $15M of shares of common stock at the public offering price.
J.P. Morgan, Leerink Partners, Morgan Stanley, and Wells Fargo Securities are acting as joint book-running managers for the offering.
The securities will be offered pursuant to a shelf registration statement filed with the SEC on March 27, 2025, and declared effective on April 15, 2025.
Shares +23.23%.

More on Kyverna Therapeutics